Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

Done Deal: Creating Anti-COVID-19 Equity

| Maryam Mahdi

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

Business & Regulation Trends & Forecasts

March’s Top Biopharma Headlines

| Stephanie Sutton

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

Business & Regulation Technology and Equipment

The 360 Virtual Tour

| Stephanie Sutton

We find out how technology is enabling remote inspections in the pharma industry.

Business & Regulation Standards & Regulation

An Ode to Flexible Cleanroom Furniture

| Sue Springett

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

Business & Regulation Business Practice

What’s in a Name?

| Maryam Mahdi

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?

Business & Regulation Standards & Regulation

The (DILI) Model of Success

| Maryam Mahdi

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

Business & Regulation Business Practice

Time Will Always Tell

| Maryam Mahdi

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Business & Regulation Business Practice

What it takes to enable tech transfer partnerships

| Thomas Cueni

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.

Discovery & Development Business Practice

“We Want to Return to the Lab”: How the Russian Invasion Has Disrupted Drug Discovery in Ukraine

| Angus Stewart

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Business & Regulation Business Practice

The Road to Digital Connectivity

| Dave Tudor

It’s time for pharma companies to embrace digital technologies.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register